Latest Chronic kidney disease Stories
LAWRENCE, Mass., May 11, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq:NXTM), a leading manufacturer of innovative dialysis products, today commented on findings of the Chronic Disease Research Group (CDRG) study showing that patients receiving daily, or more frequent, home hemodialysis with the NxStage System One(TM) are more likely to receive a kidney transplant when compared with conventional thrice-weekly dialysis, particularly in patients not on the transplant waitlist...
MARKHAM, ON, May 11, 2012 /PRNewswire/ - Cytochroma today announced positive clinical trial results for its lead product, CTAP101 Capsules. In a recently completed Phase 2b trial, CTAP101 Capsules effectively and safely lowered elevated plasma intact parathyroid hormone (iPTH) in patients with Stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency. These findings, as well as two other presentations on CTAP101 Capsules, are being featured at the National Kidney...
CHICAGO, May 10, 2012 /PRNewswire/ -- A celebrity chef presentation, free food samples and free health screenings are on tap for the American Kidney Fund's (AKF) Kidney Action Day in Chicago, May 12, from 11:00 a.m. to 3:00 p.m. Kidney Action Day, free and open to the public, will be held at Trinity United Church of Christ, 400 W. 95th Street, and will feature health screenings, entertainment, fitness demonstrations, and healthy cooking demonstrations by celebrity Chicago Chef...
Equation may provide more accurate risk prediction of death, end-stage renal disease for patients with impaired kidney function Kamyar Kalantar-Zadeh, M.D., M.P.H., Ph.D., principal investigator at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), is the author of an invited editorial in JAMA. The editorial accompanied a study that included data from more than 1 million adults, and indicated the use of a newer risk prediction equation that classified...
RIVER EDGE, N.J., April 30, 2012 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications and advanced water purification solutions, today announced the Company has received 510(k) clearance from the Food and Drug Administration ("FDA") to market its Hemodiafiltration ("HDF") system for the treatment of chronic renal failure when used with UF controlled dialysis machines capable of...
2005 policy has improved children's access to deceased-donor kidneys Highlights: A policy instituted in 2005 has reduced racial disparities in deceased-donor kidney transplantation among children. Since the institution of the policy, called Share 35, fewer children receive kidneys from living donors. More than 800 children and adolescents in the U.S. are waiting for a kidney transplant. A policy instituted in 2005 has reduced racial disparities in kidney transplantation among...
Patients suffering with end-stage renal disease could increase their survival chances by undergoing intensive dialysis at home rather than the conventional dialysis in clinics. A new study by Lawson Health Research Institute shows the potential of more intensive dialysis completed in a home setting. The study found that patients who underwent intensive dialysis at home have better survival rates than patients who had conventional dialysis in clinics. Intensive dialysis patients also had...
Information may not help reveal care that kidney disease patients receive Highlights: Information on a mandatory Medicare form regarding the care that older chronic kidney disease patients receive doesn't match the actual care that is billed by physicians. Better accuracy and consistency are needed when clinicians complete this form and submit it to Medicare. Information on a mandatory Medicare form meant to help officials assess the quality of care provided to older kidney disease...
SEATTLE, April 19, 2012 /PRNewswire/ -- Northwest Kidney Centers has launched a campaign to raise $1.5 million of the $5 million needed to turn its 700 Broadway building into a comprehensive kidney resource center. The center supports the three key areas of the nonprofit's mission - patient care, education and research. Northwest Kidney Centers, which is celebrating its 50th anniversary as the first dialysis organization in the world - has already raised $1.25 million thanks to...
DUBLIN, April 12, 2012 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has signed an agreement to acquire substantially all the assets of Pervasis Therapeutics. Shire will provide Pervasis with an upfront payment, plus potential post-closing milestone payments that are dependent on Shire's achievement of certain clinical development, regulatory and sales targets. - Clinical stage...
